Reginald Hislop III is a nationally recognized healthcare executive, consultant, strategist, and advisor with over 30 years of experience in executive leadership and business development. His expertise spans healthcare operations, mergers and acquisitions (M&A), financial strategy, and market expansion, making him a sought-after leader in the industry.
Throughout his career, Reginald has successfully led organizations ranging from $25M to $100M+, overseeing skilled nursing facilities (SNFs), home health agencies (HHAs), hospice care, medical clinics, pharmacies, mental health services, outpatient clinics, and senior living communities. His ability to expand enterprise vision and drive superior business growth has earned him a reputation for transforming businesses in demanding markets.
Reginald is also a patent-awarded developer in chronic disease management systems, telehealth, and remote disease monitoring, with FDA approval for a Class III Medical Device. His contributions to telehealth and remote patient care have positioned him as a leader in healthcare innovation and technology.
In addition to his executive roles, Reginald has a strong track record in M&A, having closed deals exceeding $500M and managed over $1B in financings, including bank debt, taxable and non-taxable bonds, and equity transactions. His financial acumen and strategic foresight have helped organizations navigate complex financial landscapes and achieve sustainable growth.
Beyond his corporate achievements, Reginald is a published author and thought leader, maintaining an internationally read blog on health policy and economics. He is also an Executive Deal Advisor for Dealexec, specializing in healthcare-focused transactions.